Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII

American Journal of Hematology
M E Rick, D M Krizek

Abstract

A patient with type 2N ("Normandy" variant) von Willebrand's disease is described. Her von Willebrand factor level was borderline low, while her factor VIII was markedly decreased to 7%. Her plasma von Willebrand factor demonstrated a decreased ability to complex with factor VIII in vitro, binding less than 10% when compared to normal plasma von Willebrand factor. The factor VIII released into the circulation after the patient received DDAVP had a shortened survival in vivo. Nucleotide sequence analysis revealed a T-to-A transition at nucleotide 2451 on both alleles. This transition results in a substitution of Gln for His at amino acid 54 in the mature subunit of von Willebrand factor.

References

Nov 1, 1978·The Journal of Clinical Investigation·J Lazarchick, L W Hoyer
Jul 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·E A TuleyC Mazurier
Apr 30, 1990·European Journal of Biochemistry·J A KoedamJ J Sixma
Jun 15, 1985·Thrombosis Research·H R GralnickM E Rick
Dec 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·K M BrinkhousM S Read
Feb 1, 1993·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Z M Ruggeri, J Ware

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.